Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang 1Paul Bastard # 2 3Zhiyong Liu # 1Jérémie Le Pen # 4Marcela Moncada-Velez # 1Jie Chen # 1Masato Ogishi # 1Ira K D Sabli # 5Stephanie Hodeib # 5Cecilia Korol # 2Jérémie Rosain # 2 3Kaya Bilguvar # 6Junqiang Ye # 7Alexandre Bolze # 8Benedetta Bigio # 1Rui Yang # 1Andrés Augusto Arias # 1 9 10Qinhua Zhou # 1Yu Zhang # 11 12Fanny Onodi 13Sarantis Korniotis 13Léa Karpf 13Quentin Philippot 2 3Marwa Chbihi 2 3Lucie Bonnet-Madin 14Karim Dorgham 15Nikaïa Smith 16William M Schneider 4Brandon S Razooky 4Hans-Heinrich Hoffmann 4Eleftherios Michailidis 4Leen Moens 17Ji Eun Han 1Lazaro Lorenzo 2 3Lucy Bizien 2 3Philip Meade 18Anna-Lena Neehus 2 3Aileen Camille Ugurbil 1Aurélien Corneau 19Gaspard Kerner 2 3Peng Zhang 1Franck Rapaport 1Yoann Seeleuthner 2 3Jeremy Manry 2 3Cecile Masson 20Yohann Schmitt 20Agatha Schlüter 21Tom Le Voyer 2 3Taushif Khan 22Juan Li 1Jacques Fellay 23 24 25Lucie Roussel 26Mohammad Shahrooei 27 28Mohammed F Alosaimi 29Davood Mansouri 30 31 32Haya Al-Saud 33Fahd Al-Mulla 34Feras Almourfi 33Saleh Zaid Al-Muhsen 35Fahad Alsohime 29Saeed Al Turki 36 37Rana Hasanato 29Diederik van de Beek 38Andrea Biondi 39Laura Rachele Bettini 39Mariella D'Angio' 39Paolo Bonfanti 40Luisa Imberti 41Alessandra Sottini 41Simone Paghera 41Eugenia Quiros-Roldan 42Camillo Rossi 43Andrew J Oler 44Miranda F Tompkins 45Camille Alba 45Isabelle Vandernoot 46Jean-Christophe Goffard 47Guillaume Smits 46Isabelle Migeotte 48Filomeen Haerynck 49Pere Soler-Palacin 50Andrea Martin-Nalda 50Roger Colobran 51Pierre-Emmanuel Morange 52Sevgi Keles 53Fatma Çölkesen 54Tayfun Ozcelik 55Kadriye Kart Yasar 56Sevtap Senoglu 56Şemsi Nur Karabela 56Carlos Rodríguez-Gallego 57 58Giuseppe Novelli 59Sami Hraiech 60Yacine Tandjaoui-Lambiotte 61 62Xavier Duval 63 64Cédric Laouénan 63 64 65COVID-STORM CliniciansCOVID CliniciansImagine COVID GroupFrench COVID Cohort Study GroupCoV-Contact CohortAmsterdam UMC Covid-19 BiobankCOVID Human Genetic EffortNIAID-USUHS/TAGC COVID Immunity GroupAndrew L Snow 66Clifton L Dalgard 45 67Joshua D Milner 68Donald C Vinh 26Trine H Mogensen 69 70Nico Marr 22 71András N Spaan 1 72Bertrand Boisson 1 2 3Stéphanie Boisson-Dupuis 1 2 3Jacinta Bustamante 1 2 3 73Anne Puel 1 2 3Michael J Ciancanelli 1 74Isabelle Meyts 17 75Tom Maniatis 7 76Vassili Soumelis 13 77Ali Amara 14Michel Nussenzweig 78 79Adolfo García-Sastre 18 80 81 82Florian Krammer 18Aurora Pujol 21Darragh Duffy 16Richard P Lifton # 83 84 85Shen-Ying Zhang # 1 2 3Guy Gorochov # 15Vivien Béziat # 1 2 3Emmanuelle Jouanguy # 1 2 3Vanessa Sancho-Shimizu # 5Charles M Rice # 4Laurent Abel # 1 2 3Luigi D Notarangelo # 11 12Aurélie Cobat # 1 2 3Helen C Su # 11 12Jean-Laurent Casanova # 86 2 3 79 87

Affiliations

23 October 2020

-

doi: 10.1126/science.abd4570


Abstract

Clinical outcome upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from silent infection to lethal coronavirus disease 2019 (COVID-19). We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection. By testing these and other rare variants at these 13 loci, we experimentally defined LOF variants underlying autosomal-recessive or autosomal-dominant deficiencies in 23 patients (3.5%) 17 to 77 years of age. We show that human fibroblasts with mutations affecting this circuit are vulnerable to SARS-CoV-2. Inborn errors of TLR3- and IRF7-dependent type I IFN immunity can underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection.


 


References

https://pubmed.ncbi.nlm.nih.gov/